PVP Ventures Ltd acquires significant stake in 7 Med India Pvt Ltd. and Epitome Group of Hospitals

PVP Ventures Ltd., ("PVP") executed binding agreements to initially acquire 41.23% stake in 7 Med India Pvt. Ltd. and Epitome Group of Hospitals ("7Med" / "Company") with a clear contracted path to majority shareholding within 12 months from date of this announcement and a defined roadmap to increase it's stake to 76% over time. With this acquisition, PVP has made a significant stride in its earlier announced plans to build a new age global Healthcare Services platform focussing on Illness, Wellness and Care.

The transaction shall be a combination of both primary and secondary stake purchase amounting to an outlay of circa INR 127 crores for this majority shareholding. The subsequent investments are subject to achievement of financial benchmarks contractually laid out over the next few years.

Headquartered in the Delhi NCR region, 7Med & Epitome Hospitals were founded and are run by a group of reputed and thought leaders in Nephrology, Urology, and Dialysis specialisations. The company today employs over 450 professionals and is spearheaded by a team of highly skilled and experienced founders who have served in leadership positions with organisations such as Fresenius Medical Care, B. Braun Medical, Medanta Group, and Fortis Group, among others. The Company is committed to bridging the care gap by providing holistic, world-class care to kidney failure patients across geographies.

The Company operates a profitable network of 22 cutting-edge establishments, including shop-in-shop dialysis centres within leading hospitals and standalone dialysis centres across 6 states, as well as 4 super-speciality hospitals with a clear focus on Nephrology and Urology.

With an EBITDA of approximately INR 10 crores in the current financial year, the Company is poised to deliver an EBITDA of INR 50 crores in the next 4 years with the current investment. It is already among the top five organised players in India's renal care space, offering the entire spectrum of dialysis services across its national footprint. With the capital infusion from PVP Ventures Ltd., the Company plans to expand its network to multiple states and significantly enhance healthcare infrastructure in Tier 2 and Tier 3 cities and towns in these identified states.

Mr. Gaurav Davda, Head of M&A and Strategy - PVP Ventures Ltd. said, "This transaction represents a significant step in our journey in creating a powerful house of brands in Healthcare Services focused on Tier 2 and Tier 3 markets in key identified specialisations. We welcome 7Med and its team into the PVP fold and look forward to enabling them to become a scaled national player in the near future".

Dr. Vijay Kher, Shareholder -7 Med India Pvt. Ltd. & Chairman - Epitome Hospitals, said ,"This collaboration marks a significant milestone in the Healthcare sector, combining clinical excellence and innovative healthcare solutions to create a stronger, more future-ready organisation for delivering affordable, high-quality kidney care. We now aim to reach new geographies, expand patient-centric healthcare services, and enhance operational efficiencies through integrated resources."

Shares of PVP Ventures Limited was last trading in BSE at Rs. 20.92 as compared to the previous close of Rs. 20.89. The total number of shares traded during the day was 25640 in over 176 trades.

The stock hit an intraday high of Rs. 21.35 and intraday low of 19.97. The net turnover during the day was Rs. 528486.00.

Source : Equity Bulls

Keywords

PVPVentures INE362A01016 RealEstate Residential Commercial BindingAgreements Acquisition 7MedIndia EpitomeGroupofHospitals